Leverage Partners Absolute Return Fund Spc Zoetis Inc. Transaction History

Leverage Partners Absolute Return Fund Spc

$76.9 Million
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$155.97 - $200.09 $935,820 - $1.2 Million	-6,000 Closed	0 $0
Q1 2022 May 06, 2022	SELL	$181.39 - $234.03 $36,459 - $47,040	-201 Reduced 3.24%	6,000 $1.13 Million
Q4 2021 Feb 11, 2022	BUY	$193.69 - $247.03 $38,931 - $49,653	201 Added 3.35%	6,201 $1.51 Million
Q4 2020 Feb 05, 2021	BUY	$157.07 - $174.35 $942,420 - $1.05 Million	6,000 New	6,000 $993,000

Others Institutions Holding ZTS

# of Institutions

1,957

Shares Held

410M

Call Options Held

1.02M

Put Options Held

1.09M

Vanguard Group Inc Valley Forge, PA

41.2M
Shares

$6.79 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

36.8M
Shares

$6.07 Billion
0.15% of portfolio
State Street Corp Boston, MA

19.8M
Shares

$3.26 Billion
0.16% of portfolio
State Farm Mutual Automobile Insurance CO Bloomington, IL

16M
Shares

$2.64 Billion
2.73% of portfolio
Alliancebernstein L.P. New York, NY

15.4M
Shares

$2.53 Billion
1.05% of portfolio

View Full List

About Zoetis Inc.

Ticker ZTS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 468,139,008
Market Cap $77.1B
Description
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...

More about ZTS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Leverage Partners Absolute Return Fund Spc, based on Form 13F filings with the SEC.

News

Stay updated on Leverage Partners Absolute Return Fund Spc with notifications on news.

Account